Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants

por Mulazzani, Elisabeth, Wagner, Danny, Havla, Joachim, Schlüter, Miriam, Meinl, Ingrid, Gerdes, Lisa-Ann, Kümpfel, Tania
Publicado 2020

Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of Plasmablasts

por Schlüter, Miriam, Oswald, Eva, Winklmeier, Stephan, Meinl, Ingrid, Havla, Joachim, Eichhorn, Peter, Meinl, Edgar, Kümpfel, Tania
Publicado 2021

Relapse-independent multiple sclerosis progression under natalizumab

por Graf, Jonas, Leussink, Verena I, Soncin, Giulia, Lepka, Klaudia, Meinl, Ingrid, Kümpfel, Tania, Meuth, Sven G, Hartung, Hans-Peter, Havla, Joachim, Aktas, Orhan, Albrecht, Philipp
Publicado 2021

Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis

por Ho, Samantha, Oswald, Eva, Wong, Hoi Kiu, Vural, Atay, Yilmaz, Vuslat, Tüzün, Erdem, Türkoğlu, Recai, Straub, Tobias, Meinl, Ingrid, Thaler, Franziska, Kümpfel, Tania, Meinl, Edgar, Mader, Simone
Publicado 2023

Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany

por Kümpfel, Tania, Thiel, Sandra, Meinl, Ingrid, Ciplea, Andrea I., Bayas, Antonios, Hoffmann, Frank, Hofstadt-van Oy, Ulrich, Hoshi, Muna, Kluge, Jakob, Ringelstein, Marius, Aktas, Orhan, Stoppe, Muriel, Walter, Annette, Weber, Martin S., Ayzenberg, Ilya, Hellwig, Kerstin
Publicado 2020